{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:19:55Z","timestamp":1772792395821,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"9171","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1016\/s0140-6736(98)05418-x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T00:46:25Z","timestamp":1027644385000},"page":"2190-2194","source":"Crossref","is-referenced-by-count":231,"title":["Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study"],"prefix":"10.1016","volume":"353","author":[{"given":"Berthold","family":"Rzany","sequence":"first","affiliation":[]},{"given":"Osvaldo","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Judith P","family":"Kelly","sequence":"additional","affiliation":[]},{"given":"Luigi","family":"Naldi","sequence":"additional","affiliation":[]},{"given":"Ariane","family":"Auquier","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Stern","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(98)05418-X_bib1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)05418-X_bib2","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(98)05418-X_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme","volume":"125","author":"Bastuji","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0190-9622(89)70176-6","article-title":"Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis","volume":"121","author":"Stern","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-4362.1993.tb02814.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in Thailand","volume":"32","author":"Leenutaphong","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell's syndrome): incidence and drug etiology in France, 1981\u20131985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0190-9622(85)70207-1","article-title":"Acute disseminated epidermal necrosis types 1, 2 and 3: study of sixty cases","volume":"13","author":"Ruiz-Maldonado","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany","volume":"127","author":"Schopf","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990\u20131992): structure and results of a population based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0895-4356(95)00004-N","article-title":"An international collaborative case-control study of severe cutaneous adverse reactions (SCAR): design and methods","volume":"48","author":"Kelly","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib12","series-title":"The pharmacological basis of therapeutics","first-page":"446","author":"Goodman","year":"1985"},{"key":"10.1016\/S0140-6736(98)05418-X_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.aje.a112220","article-title":"Estimability and estimation in case-referent studies","volume":"109","author":"Miettinen","year":"1976","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/106002809703100609","article-title":"Suspected lamotrigine-induced toxic epidermal necrolysis","volume":"31","author":"Chaffin","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S0140-6736(98)05418-X_bib15","first-page":"1301","article-title":"Lamotrigine versus carbamazepine in epilepsy","volume":"345","author":"Duval","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(98)05418-X_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1059-1311(97)80055-6","article-title":"Toxic epidermal necrolysis after treatment with lamotrigine","volume":"6","author":"Fogh","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/S0140-6736(98)05418-X_bib17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(05)66227-7","article-title":"Lamotrigine and toxic epidermal necrolysis","volume":"348","author":"Sachs","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(98)05418-X_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1440-0960.1996.tb01057.x","article-title":"Lamotrigine-induced toxic epidermal necrolysis treated with intravenous ciclosporin: a discussion of pathogenesis and immunosuppressive management","volume":"37","author":"Sullivan","year":"1996","journal-title":"Australas J Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(05)64979-3","article-title":"Lamotrigine and toxic epidermal necrolysis","volume":"348","author":"Wadelius","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(98)05418-X_bib20","first-page":"595","article-title":"Fatal course of toxic epidermal necrolysis under treatment with lamotrigine","volume":"33","author":"Sterker","year":"1995","journal-title":"Int J Pharmacol Ther"},{"key":"10.1016\/S0140-6736(98)05418-X_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1673.1995.tb00230.x","article-title":"Is phenytoin contraindicated in patients receiving cranial irradiation?","volume":"39","author":"Borg","year":"1995","journal-title":"Australas Radiol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.38.2.194","article-title":"Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin","volume":"38","author":"Delattre","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)05418-X_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(85)90099-6","article-title":"Stevens-Johnson syndrome in patients receiving radiation therapy","volume":"ii","author":"Maiche","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(98)05418-X_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1259\/0007-1285-45-538-768","article-title":"Severe erythema multiforme (Stevens-Johnson syndrome) following telecobalt therapy","volume":"45","author":"Nawalkha","year":"1972","journal-title":"Br J Radiol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archderm.1997.03890430055008","article-title":"Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome","volume":"133","author":"Inachi","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/S0140-6736(98)05418-X_bib27","first-page":"991","article-title":"Weichselbaum R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha and ceramide","volume":"55","author":"Chen","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(98)05418-X_bib28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(95)00214-8","article-title":"Radiation-induced apoptosis: relevance to radiotherapy","volume":"33","author":"Dewey","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0140-6736(98)05418-X_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0404.1990.tb00949.x","article-title":"Epidemiology of adverse reactions to carbamazepine as seen in spontaneous reporting systems","volume":"81","author":"Asmark","year":"1990","journal-title":"Acta Neurol Scand"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067369805418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067369805418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T00:05:31Z","timestamp":1531526731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067369805418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":29,"journal-issue":{"issue":"9171","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["S014067369805418X"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(98)05418-x","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}